Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enovis (GB:0I1B)
LSE:0I1B
Enovis (0I1B) Share Price & Analysis
1 Followers
0I1B Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$43.31 - $65.36
Previous Close$52.32
Volume79.00
Average Volume (3M)28.32K
Market Cap
$2.81B
Enterprise Value$3.24B
Total Cash (Recent Filing)$36.19M
Total Debt (Recent Filing)$466.16M
Price to Earnings (P/E)N/A
Beta0.57
Next Earnings
Aug 01, 2024EPS EstimateN/A
Last Dividend Ex-Date
Apr 05, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding54,850,906
10 Day Avg. Volume2
30 Day Avg. Volume28,318
Standard Deviation0.16
R-Squared0.35
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)12.22
Price to Sales (P/S)3.82
Price to Cash Flow (P/CF)10.30
P/FCF Ratio16.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.90
Enterprise Value/Gross Profit3.27
Enterprise Value/Ebitda19.12
Forecast
1Y Price Target
$76.83Price Target Upside46.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Enovis News
Bulls Say, Bears Say
Bulls Say
Corporate GrowthContinuous innovation and portfolio diversification have led to significant market share gains in key segments.
Financial PerformanceAnalyst maintains Outperform rating and raises price target, anticipating solid top-line performance and Lima synergies ahead.
Strategic InitiativesENOV's valuation appears very attractive compared to its peers, suggesting upside potential at current trading levels.
Bears Say
Financial PerformanceCore EPS guidance falls below expectations due to higher depreciation and tax rate.
Management GuidanceAnalysts express concerns about potentially too conservative guidance for Lima.
Revenue GrowthRevenue growth slowed due to Lima dis-synergies.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
7.51% Other Institutional Investors
92.49% Public Companies and
Individual Investors
0I1B FAQ
What was Enovis’s price range in the past 12 months?
Enovis lowest share price was $43.31 and its highest was $65.36 in the past 12 months.
What is Enovis’s market cap?
Currently, no data Available
When is Enovis’s upcoming earnings report date?
Enovis’s upcoming earnings report date is Aug 01, 2024 which is in 87 days.
How were Enovis’s earnings last quarter?
Enovis released its earnings results on May 02, 2024. The company reported $0.5 earnings per share for the quarter, beating the consensus estimate of $0.484 by $0.016.
Is Enovis overvalued?
According to Wall Street analysts Enovis’s price is currently Undervalued.
Does Enovis pay dividends?
Enovis pays a Notavailable dividend of $16.67 which represents an annual dividend yield of N/A. See more information on Enovis dividends here
What is Enovis’s EPS estimate?
Enovis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enovis have?
Currently, no data Available
What happened to Enovis’s price movement after its last earnings report?
Enovis reported an EPS of $0.5 in its last earnings report, beating expectations of $0.484. Following the earnings report the stock price went down -5.987%.
Which hedge fund is a major shareholder of Enovis?
Among the largest hedge funds holding Enovis’s share is Diamond Hill Capital Management Inc. It holds Enovis’s shares valued at 140M.
---
Enovis Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$76.83 (46.85% Upside)
$76.83 (46.85% Upside)
Blogger Sentiment
Bullish
GB:0I1B Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.38%
12-Months-Change
Fundamentals
Return on Equity
-3.06%
Trailing 12-Months
Asset Growth
27.42%
Trailing 12-Months
Company Description
Enovis
Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.
---
0I1B Company Deck
---
0I1B Earnings Call
Q1 2024
0:00 / 0:00
---
0I1B Stock 12 Months Forecast
Average Price Target
$76.83
▲(46.85% Upside)
Technical Analysis
Best Analysts Covering 0I1B
1 Year
---